COVID-19 Testing Update, 2021

The global COVID-19 pandemic has profoundly transformed the diagnostic industry, creating an unprecedented demand for test products and leading to significant market growth. Kalorama Information’s COVID-19 Testing Update, 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends report offers an in-depth analysis of this rapidly evolving market, focusing on molecular, antigen, and antibody tests.

 

Key Features of the Report:

• Market Impact: Analysis of how COVID-19 has reshaped the in vitro diagnostic (IVD) market, including revenue increases, company expansions, and the launch of new products.
• Technological Advancements: New features in test products such as variant and mutation detection, combination testing with flu and RSV, more specific antibody detection, and ultra-large volume capacities.

 

Scope of the Report:

• Disease Overview: Progress, trends, and developments in COVID-19.
• Mutations: Impact of SARS-CoV-2 variants on testing.
• Home Testing: Rise and potential of at-home COVID-19 tests.
• Market Data:
  • COVID-19 Antigen Tests (2020 and 2021)
  • COVID-19 Molecular Tests (2020 and 2021)
  • COVID-19 Antibody Tests (2020 and 2021)
  • Market breakdown by geography (US, Europe, Asia, Rest of World)
• Product Listings:
  • Antigen Products
  • PCR and Other Molecular Products
• Regulatory Updates: FDA Emergency Authorized Tests (Molecular, Antigen, and Antibody)
• Vaccine Impact: Analysis of the effects of vaccination on the testing market.

 

Competitive Analysis:

• New Entrants: Companies entering the diagnostics market due to the pandemic.
• Major IVD Players: Impact of COVID-19 on their performance, including expansions, acquisitions, and new product launches.

 

Key Trends Examined:

• Biden Administration Plans: Impact of government spending on the test markets.
• Home Testing: Growth of at-home testing beyond glucose, ovulation, and low-volume infectious tests.
• Mutations: Analysis of SARS-CoV-2 mutations and their implications for diagnostics.
• Vaccines: Examination of how widespread vaccination affects the demand for COVID-19 tests.
• Endemic Status: Potential for COVID-19 to become an endemic virus with recurring outbreaks.
• Supply Shortages: Challenges in the supply chain for molecular testing and implications for future testing.
• Larger Test Volumes: Lasting changes in lab medicine due to increased test volumes.

 

Table: Regional Breakout of COVID-19 Testing Market, 2020-2021 ($ millions)

Item/Year	2020	2021	% Change
North America	$XX Millions	$XX Millions	XX%
Europe	$XX Millions	$XX Millions	XX%
APAC	$XX Millions	$XX Millions	XX%
LATAM	$XX Millions	$XX Millions	XX%
ROW	$XX Millions	$XX Millions	XX%
Total	$XX Millions	$XX Millions	XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.